NeuroMetrix, Inc. (NURO) earnings
Quarterly and annual NURO reports and results, each read against the price at its own news timestamp. Back to the NURO overview →
9 measured NURO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +7.51% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +0.48% | |
| Form 10-Q NeuroMetrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.84% | |
| Form 10-Q NeuroMetrix, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -8.61% | |
| NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call | Press release | — | +1.25% | |
| Form 10-Q NeuroMetrix, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -1.87% | |
| Form 10-K NeuroMetrix, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.75% | -5.03% | |
| Form 10-Q NeuroMetrix, Inc. For: Sep 30 | SEC filing · Form 10-Q | +7.37% | -2.80% | |
| NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call | Press release | +2.94% | -4.38% |
Keep exploring
More NURO: analyst actions → · SEC filings → · NURO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ImmuCell Corporation (ICCC) | 159 | 0.00% | 42% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| Leap Therapeutics, Inc. (LPTX) | 156 | -0.69% | 43% |
| GOLD FINDER RES LTD (GLDFF) | 155 | +0.19% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.